The MHRA have issued new guidance stating that Valproate medicines (Epilim▼, Depakote▼) are contraindicated in women and girls of childbearing potential unless a Pregnancy Prevention Programme is in place.
Read the full update here: https://www.gov.uk/drug-safety-update/valproate-medicines-epilim-depakote-contraindicated-in-women-and-girls-of-childbearing-potential-unless-conditions-of-pregnancy-prevention-programme-are-met
NICE has recently updated its guidance on ‘Type 2 diabetes in adults: management’. In a change to national guidance modified‑release metformin alongside an SGLT2 inhibitor is now recommended as first‑line treatment for adults with type 2 diabetes mellitus....
We are pleased to announce the launch of our new elearning module, Pharmaceutical Management of Neonates: Use of the BABY FLAMINGo! Tool. Designed for pharmacists caring for neonatal patients, this module provides core knowledge to support systematic...
We are delighted to welcome the newest member of the SCRIPT Team, Divya Singh who joins us as a Research Associate. Divya holds a BSc in Biochemistry and a Master of Public Health (MPH) from the University of Birmingham. Before joining SCRIPT, she spent a year at the...
This month, we are celebrating 15 years of SCRIPT eLearning. In 2010, we launched our first six modules, aiming to improve prescribing competency among foundation doctors. Since then, we have come a long way and achieved some incredible milestones, including expanding...